REQUEST A DEMO
Total
USD $0.00
Search more companies

Ikar Apteka Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Warehousing and Storage | Employment Placement Agencies
Full name: Ikar Apteka Sp. z o.o. Profile Updated: January 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Ikar Apteka Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The company operates in the Department Stores sector. Ikar Apteka Sp. z o.o. was incorporated on October 01, 2015. 10 (2013) employees currently work for Ikar Apteka Sp. z o.o.. The latest financial highlights indicate a net sales revenue increase of 19.75% in 2024. Its total assets grew by 24.9% over the same period. The net profit margin of Ikar Apteka Sp. z o.o. increased by 3.35% in 2024.

Headquarters
Ul. Zwirki I Wigury 16A/Biuro 315
Warsaw; Mazowieckie; Postal Code: 02-092

Contact Details: Purchase the Ikar Apteka Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Ikar Apteka Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ikar Apteka Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ikar Apteka Sp. z o.o. report to view the information.
Incorporation Date:
October 01, 2015
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ikar Apteka Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
19.75%
Total operating revenue
21.44%
Operating profit (EBIT)
6126.87%
EBITDA
576.36%
Net Profit (Loss) for the Period
1402.95%
Total Assets
24.9%
Total Equity
59.28%
Operating Profit Margin (ROS)
3.79%
Net Profit Margin
3.35%
Return on Equity (ROE)
33.28%
Quick Ratio
0.06%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?